News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gene By Gene Rejects BRCA1/2 Patent Infringement Claims by Myriad Genetics, Inc. (MYGN) and Joins Ambry Genetics to Sue Myriad for Violating Federal Antitrust Laws


8/15/2013 7:12:46 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Gene By Gene Rejects BRCA1/2 Patent Infringement Claims by Myriad and Joins Ambry Genetics to Sue Myriad for Violating Federal Antitrust Laws

HOUSTON
, Aug. 15, 2013 /PRNewswire/ -- Gene By Gene, Ltd. announced that it is teaming with Ambry Genetics to defend against Myriad Genetics' patent infringement lawsuits against both companies in connection with the BRCA1/2 tests being offered by Gene By Gene and Ambry Genetics. Both companies are also countersuing Myriad for violations of the Federal Antitrust Act.

On June 13, 2013, immediately following the United States Supreme Court's 9-0 landmark decision against Myriad in "Association For Molecular Pathology v. Myriad Genetics," Gene By Gene announced its intention to offer fast, accurate and affordable BRCA1/2 testing to the public.

"The Supreme Court was very clear that gene sequences, even when isolated, cannot be patented," said Gene By Gene President Bennett Greenspan. "In light of this ruling we are pleased that we can now offer Americans the benefit of this more affordable test that we have already successfully offered to overseas clients."

Gene By Gene has been providing BRCA1/2 tests to individuals outside the U.S. since 2012. Those tests are processed at the company's Genomic Research Center in Houston, a CLIA-registered lab. The company has processed various genetic tests including BRCA1/2 -- for close to a million individuals and organizations globally.

Yesterday Gene By Gene also filed a declaration with the court outlining the details of its BRCA1/2 test, which it will continue to offer to the public.

Greenspan added, "We look forward to a swift resolution of this litigation to level the playing field for test providers, and to enable greater numbers of people to benefit from the genomics revolution."

About Gene By Gene Ltd.

Founded in 2000, Gene By Gene, Ltd. provides reliable DNA testing, focused on ancestry, health, research and paternity, to a wide range of consumer and institutional customers. Gene By Gene provides DNA tests through its Family Tree DNA division, which pioneered the concept of direct-to­consumer (DTC) testing in the field of genetic genealogy more than a decade ago. Gene By Gene is CLIA registered and through its clinical health division offers regulated diagnostic tests. The Research Use Only (RUO) division serves both DTC and institutional clients worldwide. Gene By Gene offers AABB certified relationship tests through its paternity testing division. The privately held company is headquartered in Houston, which is also home to its state-of-the-art Genomics Research Center.

Media Contact:

For Gene By Gene, Ltd.
Kate Croft
Casteel Schoenborn
croft@csirfirm.com
888-609-8351

SOURCE Gene By Gene, Ltd.



Help employers find you! Check out all the jobs and post your resume.
Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES